INGREDION INC
INGRNYSE🏆 #1133 by market capEarnings Nov 5 · PreUS Equity
$94.25▼ $0.46 (−0.49%)
Market closed · at closeTrack INGR
Get earnings, price moves & breaking news on Telegram
24h▼ 0.5%
7d▼ 3.1%
14d▼ 3.2%
30d▼ 2.3%
ytd▼ 14.5%
1y▼ 18.6%
🏦Market Cap
$5.94B
Small Cap
📈Revenue Growth (YoY)
-1.4%
Declining
📊Gross Margin
23.7%
Moderate
💵FCF Margin
7.3%
Moderate
⚖️P/S Ratio
0.8x
Cheap
Otter Score
60
Fair
INGREDION INC
INGRAnalyst Ratings
Price
$94.25
Total
21
Raised
2
Lowered
6
Avg PT
$109.50
H / L
$115 / $104
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Barclays | Reiterated | Equal Weight | 2026-10-14 | $115.00 | +22.00% |
UBS | Reiterated | Neutral | 2026-10-05 | $104.00 | +10.30% |
Oppenheimer | Downgraded | Outperform → Perform | 2026-06-09 | $136.00 | +44.30% |
Stephens & Co. | Reiterated | Equal Weight | 2026-02-04 | — | — |
BMO Capital | Reiterated | Market Perform | 2025-11-05 | $123.00 | +30.50% |
Goldman Sachs | Reiterated | Buy | 2024-02-16 | $135.00 | +43.20% |
Credit Suisse | Reiterated | Neutral | 2023-02-09 | — | — |
Berenberg | Reiterated | Buy | 2020-07-16 | — | — |
Citigroup | Reiterated | Neutral | 2019-08-06 | — | — |
Vertical Group | Downgraded | Buy → Hold | 2019-01-24 | — | — |
Vertical Research | Downgraded | Buy → Hold | 2019-01-24 | — | — |
Jefferies | Reiterated | Buy | 2016-11-30 | — | — |
Tigress Financial | Reiterated | Underperform | 2015-12-23 | — | — |
Canaccord Genuity | Reiterated | Buy | 2015-06-25 | — | — |
Standpoint Research | Downgraded | Buy → Hold | 2014-11-18 | — | — |
Standpoint | Upgraded | Hold → Buy | 2014-10-14 | — | — |
BB&T Capital | Downgraded | Buy → Hold | 2014-06-18 | — | — |
KeyBanc | Reiterated | Buy | 2014-06-17 | — | — |
Keybanc | Reiterated | Buy | 2014-06-17 | — | — |
Davenport | Upgraded | Neutral → Buy | 2013-08-01 | — | — |
Gabelli & Co. | Downgraded | Buy → Hold | 2013-07-16 | — | — |
Institution
Barclays
Reiterated · Equal Weight · 2026-10-14
$115.00
+22.00%
UBS
Reiterated · Neutral · 2026-10-05
$104.00
+10.30%
Oppenheimer
Downgraded · Outperform → Perform · 2026-06-09
$136.00
+44.30%
Stephens & Co.
Reiterated · Equal Weight · 2026-02-04
—
—
BMO Capital
Reiterated · Market Perform · 2025-11-05
$123.00
+30.50%
Goldman Sachs
Reiterated · Buy · 2024-02-16
$135.00
+43.20%
Credit Suisse
Reiterated · Neutral · 2023-02-09
—
—
Berenberg
Reiterated · Buy · 2020-07-16
—
—
Citigroup
Reiterated · Neutral · 2019-08-06
—
—
Vertical Group
Downgraded · Buy → Hold · 2019-01-24
—
—
Vertical Research
Downgraded · Buy → Hold · 2019-01-24
—
—
Jefferies
Reiterated · Buy · 2016-11-30
—
—
Tigress Financial
Reiterated · Underperform · 2015-12-23
—
—
Canaccord Genuity
Reiterated · Buy · 2015-06-25
—
—
Standpoint Research
Downgraded · Buy → Hold · 2014-11-18
—
—
Standpoint
Upgraded · Hold → Buy · 2014-10-14
—
—
BB&T Capital
Downgraded · Buy → Hold · 2014-06-18
—
—
KeyBanc
Reiterated · Buy · 2014-06-17
—
—
Keybanc
Reiterated · Buy · 2014-06-17
—
—
Davenport
Upgraded · Neutral → Buy · 2013-08-01
—
—
Gabelli & Co.
Downgraded · Buy → Hold · 2013-07-16
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space